 |
|
Emerging medical therapies for severe alcoholic hepatitis
David Tornai, Gyongyi Szabo
Clin Mol Hepatol. 2020;26(4):686-696. Published online 2020 Sep 28 DOI: https://doi.org/10.3350/cmh.2020.0145
|
|
Citations to this article as recorded by
 New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey’s discriminant function <32
Tae Hyung Kim, Hyung Joon Yim, Young Kul Jung, Do Seon Song, Eileen L. Yoon, Hee Yeon Kim, Seong Hee Kang, Young Chang, Jeong-Ju Yoo, Baek Gyu Jun, Sung Won Lee, Jung Gil Park, Ji Won Park, Sung-Eun Kim, Tae Yeob Kim, Soung Won Jeong, Ki Tae Suk, Moon You
Hepatology International.2024; 18(2): 500. CrossRef Alcohol-Related Liver Disease Including New Developments
Parita Virendra Patel, Steven L. Flamm
Clinics in Liver Disease.2023; 27(1): 157. CrossRef Role of rifaximin in the management of alcohol‐associated hepatitis: A systematic review and meta‐analysis
Zohaib Ahmed, Joyce Badal, Mohamad Nawras, Dhanushya Battepati, Umer Farooq, Syeda Faiza Arif, Wade Lee‐Smith, Muhammad Aziz, Umair Iqbal, Ahmad Nawaz, Manesh Kumar Gangwani, Amna Iqbal, Abdallah Kobeissy, Benyam D Addissie, Mona Hassan, Sammy Saab
Journal of Gastroenterology and Hepatology.2023; 38(5): 703. CrossRef Current and emerging therapies for alcohol-associated hepatitis
Francisco Idalsoaga, Gustavo Ayares, Luis Antonio Díaz, Jorge Arnold, María Ayala-Valverde, David Hudson, Marco Arrese, Juan Pablo Arab
Liver Research.2023; 7(1): 35. CrossRef Tgr5 −/− mice are protected from ethanol-induced metabolic alterations through enhanced leptin and Fgf21 signaling
Sabita Pokhrel, Matthew Dilts, Zachary Stahl, Shannon Boehme, Gabrielle Frame, John Y.L. Chiang, Jessica M. Ferrell
Hepatology Communications.2023;[Epub] CrossRef Therapeutic targets in alcohol-associated liver disease: progress and challenges
Ayooluwatomiwa Deborah Adekunle, Adeyinka Adejumo, Ashwani K. Singal
Therapeutic Advances in Gastroenterology.2023; 16: 175628482311709. CrossRef A Review on “IL-1 Receptor Antagonist Plus Pentoxifylline and Zinc for Severe Alcohol-Associated Hepatitis”
Shrihari Anikhindi, Akshay Anikhindi, Ashish Kumar, Anil Arora
Journal of Clinical and Experimental Hepatology.2023; 13(3): 533. CrossRef A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: A multicenter plasma biomarker analysis
David Tornai, Mack Mitchell, Craig J. McClain, Srinivasan Dasarathy, Arthur McCullough, Svetlana Radaeva, Aimee Kroll-Desrosiers, JungAe Lee, Bruce Barton, Gyongyi Szabo
Hepatology Communications.2023;[Epub] CrossRef Current Medical Treatment for Alcohol-Associated Liver Disease
Gustavo Ayares, Francisco Idalsoaga, Luis A. Díaz, Jorge Arnold, Juan P. Arab
Journal of Clinical and Experimental Hepatology.2022; 12(5): 1333. CrossRef Transplant in acute alcoholic hepatitis: a relative contraindication
Neha Jakhete, Ameer Abutaleb, Kirti Shetty
Current Opinion in Organ Transplantation.2022; 27(2): 93. CrossRef Mesenchymal stem cells-based therapy in liver diseases
Heng-Tong Han, Wei-Lin Jin, Xun Li
Molecular Biomedicine.2022;[Epub] CrossRef The role of gut microbiota in liver regeneration
Zhe Xu, Nan Jiang, Yuanyuan Xiao, Kefei Yuan, Zhen Wang
Frontiers in Immunology.2022;[Epub] CrossRef Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives
Yoonji Ha, Inju Jeong, Tae Hyun Kim
Biomedicines.2022; 10(10): 2530. CrossRef Innate immune activation: Parallels in alcohol use disorder and Alzheimer’s disease
Adriana Ramos, Radhika S. Joshi, Gyongyi Szabo
Frontiers in Molecular Neuroscience.2022;[Epub] CrossRef Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives
Szu-Yi Liu, I-Ting Tsai, Yin-Chou Hsu
International Journal of Molecular Sciences.2021; 22(10): 5170. CrossRef
|